<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36908615</PMID><DateRevised><Year>2023</Year><Month>06</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-2295</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in neurology</Title><ISOAbbreviation>Front Neurol</ISOAbbreviation></Journal><ArticleTitle>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): Results from a post-COVID-19 multidisciplinary clinic.</ArticleTitle><Pagination><StartPage>1090747</StartPage><MedlinePgn>1090747</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1090747</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fneur.2023.1090747</ELocationID><Abstract><AbstractText Label="BACKGROUND">The global prevalence of PASC is estimated to be present in 0&#xb7;43 and based on the WHO estimation of 470 million worldwide COVID-19 infections, corresponds to around 200 million people experiencing long COVID symptoms. Despite this, its clinical features are not well-defined.</AbstractText><AbstractText Label="METHODS">We collected retrospective data from 140 patients with PASC in a post-COVID-19 clinic on demographics, risk factors, illness severity (graded as one-mild to five-severe), functional status, and 29 symptoms and principal component symptoms cluster analysis. The Institute of Medicine (IOM) 2015 criteria were used to determine the Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) phenotype.</AbstractText><AbstractText Label="FINDINGS">The median age was 47 years, 59.0% were female; 49.3% White, 17.2% Hispanic, 14.9% Asian, and 6.7% Black. Only 12.7% required hospitalization. Seventy-two (53.5%) patients had no known comorbid conditions. Forty-five (33.9%) were significantly debilitated. The median duration of symptoms was 285.5 days, and the number of symptoms was 12. The most common symptoms were fatigue (86.5%), post-exertional malaise (82.8%), brain fog (81.2%), unrefreshing sleep (76.7%), and lethargy (74.6%). Forty-three percent fit the criteria for ME/CFS, majority were female, and obesity (BMI &gt; 30 Kg/m<sup>2</sup>) (<i>P</i> = 0.00377895) and worse functional status (<i>P</i> = 0.0110474) were significantly associated with ME/CFS.</AbstractText><AbstractText Label="INTERPRETATIONS">Most PASC patients evaluated at our clinic had no comorbid condition and were not hospitalized for acute COVID-19. One-third of patients experienced a severe decline in their functional status. About 43% had the ME/CFS subtype.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Bonilla, Quach, Tiwari, Bonilla, Miglis, Yang, Eggert, Sharifi, Horomanski, Subramanian, Smirnoff, Simpson, Halawi, Sum-ping, Kalinowski, Patel, Shafer and Geng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bonilla</LastName><ForeName>Hector</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quach</LastName><ForeName>Tom C</ForeName><Initials>TC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tiwari</LastName><ForeName>Anushri</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla</LastName><ForeName>Andres E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Molecular, Cell and Developmental Biology, University of Michigan, Ann Arbor, MI, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miglis</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Phillip C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eggert</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharifi</LastName><ForeName>Husham</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horomanski</LastName><ForeName>Audra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Subramanian</LastName><ForeName>Aruna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smirnoff</LastName><ForeName>Liza</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simpson</LastName><ForeName>Norah</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halawi</LastName><ForeName>Houssan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sum-Ping</LastName><ForeName>Oliver</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalinowski</LastName><ForeName>Agnieszka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Zara M</ForeName><Initials>ZM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shafer</LastName><ForeName>Robert William</ForeName><Initials>RW</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Linda N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Department of Medicine, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Neurol</MedlineTA><NlmUniqueID>101546899</NlmUniqueID><ISSNLinking>1664-2295</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ME/CFS</Keyword><Keyword MajorTopicYN="N">PASC</Keyword><Keyword MajorTopicYN="N">post-COVID-19 clinic</Keyword><Keyword MajorTopicYN="N">prevalence</Keyword><Keyword MajorTopicYN="N">symptoms</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>1</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>3</Month><Day>13</Day><Hour>3</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>3</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>2</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36908615</ArticleId><ArticleId IdType="pmc">PMC9998690</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files DC, et al. . Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a Multistate Health care systems network - United States, March-June 2020. MMWR Morb Mortal Wkly Rep. (2020) 69:993&#x2013;8. 10.15585/mmwr.mm6930e1</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. (2022) 226:1593&#x2013;1607. 10.1101/2021.11.15.21266377</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.15.21266377</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Malkova A, Kudryavtsev I, Starshinova A, Kudlay D, Zinchenko Y, Glushkova A, et al. . Post COVID-19 syndrome in patients with asymptomatic/mild form. Pathogens. (2021) 10:1408. 10.3390/pathogens10111408</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111408</ArticleId><ArticleId IdType="pmc">PMC8620929</ArticleId><ArticleId IdType="pubmed">34832564</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . Long COVID or Post-COVID Conditions. Atlanta, GA: CDC; (2022).</Citation></Reference><Reference><Citation>COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. London: National Institute for Health and Care Excellence: Clinical Guidelines; (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. (2022) 22:e102&#x2013;7. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Aapmr&amp;r . Post-Acute Sequelae of SARS-CoV-2 Infections (PASC) Estimates and Insights. (2022). 10.51648/jac.57</Citation><ArticleIdList><ArticleId IdType="doi">10.51648/jac.57</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re'em Y, et al. . Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. The National Academies Collection: Reports funded by National Institutes of Health. Washington (DC) (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. (2020) 18:100. 10.1186/s12967-020-02269-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02269-0</ArticleId><ArticleId IdType="pmc">PMC7038594</ArticleId><ArticleId IdType="pubmed">32093722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. (2021) 9:927&#x2013;37. 10.1016/j.jchf.2021.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Meyer-Arndt L, Wittke K, Zoller T, Steinbeis F, Haffke M, et al. . Chronic COVID-19 Syndrome and Chronic Fatigue Syndrome (ME/CFS) following the first pandemic wave in Germany: a first analysis of a prospective observational study. medRxiv. (2021). 10.1101/2021.02.06.21249256</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.06.21249256</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Boon G, Barco S, Endres M, Geelhoed JJM, Knauss S, et al. . The Post-COVID-19 functional status scale: a tool to measure functional status over time after COVID-19. Eur Respir J. (2020) 56:2001494. 10.1183/13993003.01494-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01494-2020</ArticleId><ArticleId IdType="pmc">PMC7236834</ArticleId><ArticleId IdType="pubmed">32398306</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xea; S JJ, Husson F. FactoMineR: an R package for multivariate analysis. J Stat Softw. (2008) 25:1&#x2013;18. 10.18637/jss.v025.i01</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v025.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassambara A. Practical Guide To Principal Component Methods in R. STHDA: (2017).</Citation></Reference><Reference><Citation>Fernandez-de-Las-Penas C, Palacios-Cena D, Gomez-Mayordomo V, Florencio LL, Cuadrado ML, Plaza-Manzano G, et al. . Prevalence of post-COVID-19 symptoms in hospitalized and non-hospitalized COVID-19 survivors: a systematic review and meta-analysis. Eur J Intern Med. (2021) 92:55&#x2013;70. 10.1016/j.ejim.2021.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.06.009</ArticleId><ArticleId IdType="pmc">PMC8206636</ArticleId><ArticleId IdType="pubmed">34167876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Grach SL, Ghosh AK, Bierle DM, Salonen BR, Collins NM, et al. . The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc. (2022) 97:454&#x2013;64. 10.1016/j.mayocp.2021.11.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.11.033</ArticleId><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Viveiros A, Rasmuson J, Vu J, Mulvagh SL, Yip CYY, Norris CM, et al. . Sex differences in COVID-19: candidate pathways, genetics of ACE2, and sex hormones. Am J Physiol Heart Circ Physiol. (2021) 320:H296&#x2013;304. 10.1152/ajpheart.00755.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00755.2020</ArticleId><ArticleId IdType="pmc">PMC8083171</ArticleId><ArticleId IdType="pubmed">33275517</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma G, Volgman AS, Michos ED. Sex differences in mortality from COVID-19 pandemic: are men vulnerable and women protected? JACC Case Rep. (2020) 2:1407&#x2013;10. 10.1016/j.jaccas.2020.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaccas.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7198137</ArticleId><ArticleId IdType="pubmed">32373791</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciarambino T, Para O, Giordano M. Immune system and COVID-19 by sex differences and age. Womens Health. (2021) 17:17455065211022262. 10.1177/17455065211022262</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17455065211022262</ArticleId><ArticleId IdType="pmc">PMC8188967</ArticleId><ArticleId IdType="pubmed">34096383</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell ML, Catalfamo CJ, Farland LV, Ernst KC, Jacobs ET, Klimentidis YC, et al. . Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS ONE. (2021) 16:e0254347. 10.1371/journal.pone.0254347</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0254347</ArticleId><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfaff ER, Girvin AT, Bennett TD, Bhatia A, Brooks IM, Deer RR, et al. . Identifying who has long COVID in the USA: a machine learning approach using N3C data. Lancet Digit Health. (2022) 4:e532&#x2013;41. 10.1016/S2589-7500(22)00048-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2589-7500(22)00048-6</ArticleId><ArticleId IdType="pmc">PMC9110014</ArticleId><ArticleId IdType="pubmed">35589549</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. (2020) 95:1445&#x2013;53. 10.1016/j.mayocp.2020.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2020.05.006</ArticleId><ArticleId IdType="pmc">PMC7236707</ArticleId><ArticleId IdType="pubmed">32622449</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano SD, Blackstock AJ, Taylor EV, El Burai Felix S, Adjei S, Singleton CM, et al. . Trends in racial and ethnic disparities in COVID-19 hospitalizations, by region - United States, March-December 2020. MMWR Morb Mortal Wkly Rep. (2021) 70:560&#x2013;5. 10.15585/mmwr.mm7015e2</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7015e2</ArticleId><ArticleId IdType="pmc">PMC8344991</ArticleId><ArticleId IdType="pubmed">33857068</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. . Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. (2021) 73:e826&#x2013;9. 10.1093/cid/ciab103</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciab103</ArticleId><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Couzin-Frankel J. Clues to long COVID. Science. (2022) 376:1261&#x2013;5. 10.1126/science.add4297</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.add4297</ArticleId><ArticleId IdType="pubmed">35709281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, et al. . Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: a prospective, multi-centre, population-based cohort study. EClinicalMedicine. (2022) 51:101549. 10.1016/j.eclinm.2022.101549</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101549</ArticleId><ArticleId IdType="pmc">PMC9289961</ArticleId><ArticleId IdType="pubmed">35875815</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. (2022) 11:269. 10.3390/pathogens11020269</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens11020269</ArticleId><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Poenaru S, Abdallah SJ, Corrales-Medina V, Cowan J. COVID-19 and post-infectious myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review. Ther Adv Infect Dis. (2021) 8:20499361211009385. 10.1177/20499361211009385</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/20499361211009385</ArticleId><ArticleId IdType="pmc">PMC8060761</ArticleId><ArticleId IdType="pubmed">33959278</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. (2006) 333:575. 10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906. 10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Vimercati L, De Maria L, Quarato M, Caputi A, Gesualdo L, Migliore G, et al. . Association between long COVID and overweight/obesity. J Clin Med. (2021) 10(18). 10.3390/jcm10184143</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10184143</ArticleId><ArticleId IdType="pmc">PMC8469321</ArticleId><ArticleId IdType="pubmed">34575251</ArticleId></ArticleIdList></Reference><Reference><Citation>Colaneri M, Novelli V, Cutti S, Muzzi A, Resani G, Monti MC, et al. . The experience of the health care workers of a severely hit SARS-CoV-2 referral Hospital in Italy: incidence, clinical course and modifiable risk factors for COVID-19 infection. J Public Health. (2021) 43:26&#x2013;34. 10.1093/pubmed/fdaa195</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdaa195</ArticleId><ArticleId IdType="pmc">PMC7665642</ArticleId><ArticleId IdType="pubmed">33140084</ArticleId></ArticleIdList></Reference><Reference><Citation>Rognvaldsson KG, Eythornorsson ES, Emilsson OI, Eysteinsdottir B, Palsson R, Gottfreethsson M, et al. . Obstructive sleep apnea is an independent risk factor for severe COVID-19: a population-based study. Sleep. (2022) 45:zsab272. 10.1093/sleep/zsab272</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/zsab272</ArticleId><ArticleId IdType="pmc">PMC8690036</ArticleId><ArticleId IdType="pubmed">34791469</ArticleId></ArticleIdList></Reference><Reference><Citation>Strausz S, Kiiskinen T, Broberg M, Ruotsalainen S, Koskela J, Bachour A, et al. . Sleep apnoea is a risk factor for severe COVID-19. BMJ Open Respir Res. (2021) 8:e000845. 10.1136/bmjresp-2020-000845</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2020-000845</ArticleId><ArticleId IdType="pmc">PMC7804843</ArticleId><ArticleId IdType="pubmed">33436406</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>